Serum endotoxins and flagellin and risk of colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC) cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 2, 2016, Pages 291-301

  Kong, So Yeon ^a   Tran, Hao Quang ^b   Gewirtz, Andrew T ^b   McKeown Eyssen, Gail ^c   Fedirko, Veronika ^d   Romieu, Isabelle ^a   Tjønneland, Anne ^e   Olsen, Anja ^e   Overvad, Kim ^f   Boutron Ruault, Marie Christine ^g,h,i   Bastide, Nadia ^g,h,i   Affret, Aurélie ^g,h,i   Kühn, Tilman ^g,h,i   Kaaks, Rudolf ^j   Boeing, Heiner ^k   Aleksandrova, Krasimira ^k   Trichopoulou, Antonia ^l,m   Kritikou, Maria ^l   Vasilopoulou, Effie ^m   Palli, Domenico ⁿ   Krogh, Vittorio ^o   Mattiello, Amalia ^p   Tumino, Rosario ^q   Naccarati, Alessio ^r   Bueno De mesquita, H B ^s,t,u,v   Peeters, Petra H ^t,u   Weiderpass, Elisabete ^w,x,y,z   Quirós, J Ramón ^aa   Sala, Núria ^ab   Sánchez, María José ^ac,ad   Castanõ, José María Huerta ^ad,ae   Barricarte, Aurelio ^ad,af,ag   Dorronsoro, Miren ^ah   Werner, Marten ^ai   Wareham, Nicholas J ^aj   Khaw, Kay Tee ^ak   Bradbury, Kathryn E ^al   Freisling, Heinz ^a   Stavropoulou, Faidra ^a   Ferrari, Pietro ^a   Gunter, Marc J ^u   Cross, Amanda J ^u   Riboli, Elio ^u   Bruce, W Robert ^c   Jenab, Mazda ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d EMORY UNIVERSITY   (United States)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^h University of Paris South   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l HELLENIC HEALTH FOUNDATION   (Greece)

^m UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁿ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^q Cancer Registry   (Italy)

^r Human Genetics Foundation   (Italy)

^s NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^t UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^u IMPERIAL COLLEGE LONDON   (United Kingdom)

^v UNIVERSITY OF MALAYA   (Malaysia)

^w UNIVERSITY OF TROMSØ   (Norway)

^x CANCER REGISTRY OF NORWAY   (Norway)

^y KAROLINSKA INSTITUTE   (Sweden)

^z FOLKHÄLSAN RESEARCH CENTER   (Finland)

^aa Public Health   (Spain)

^ab CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ac ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ad CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ae DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^af INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ag Recinto de Complejo Hospitalario de Navarra   (Spain)

^ah BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ai UMEÅ UNIVERSITY   (Sweden)

^aj ADDENBROOKE S HOSPITAL   (United Kingdom)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; BIOLOGICAL MARKER; ENDOTOXIN; FLAGELLIN;

ADULT; ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; BODY MASS; BODY SIZE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENERGY CONSUMPTION; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RECTUM CANCER; RISK REDUCTION; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE; BLOOD; COLORECTAL NEOPLASMS; EUROPE; NUTRITIONAL ASSESSMENT; PROSPECTIVE STUDY; RISK FACTOR;

BIOMARKERS; COHORT STUDIES; COLORECTAL NEOPLASMS; ENDOTOXINS; EUROPE; FEMALE; FLAGELLIN; HUMANS; MALE; NUTRITION ASSESSMENT; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84957801112     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0798     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 2007;10:729-34.
3. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacteria and host interactions in the gut epithelial barrier. Nat Chem Biol 2012;8:36-45.
4. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105: 1907-11.
5. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011;34:392-7.
6. Sanders CJ, Yu Y, Moore DA 3rd, Williams IR, Gewirtz AT. Humoral immune response to flagellin requires T cells and activation of innate immunity. J Immunol 2006;177:2810-8.
7. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008;87:1219-23.
8. Atreya R, Neurath MF. Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 2008;9:369-74.
9. Nimptsch K, Aleksandrova K, Boeing H, Janke J, Lee YA, Jenab M, et al. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk. Int J Cancer 2015;136:1181-92.
10. Ziegler TR, Luo M, Estivariz CF, Moore DA 3rd, Sitaraman SV, Hao L, et al. Detectable serum flagellin and lipopolysaccharide and upregulated antiflagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol 2008;294:R402-10.
11. Sitaraman SV, Klapproth JM, Moore DA 3rd, Landers C, Targan S, Williams IR, et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005;288:G403-6.
12. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004;113:1296-306.
13. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects andmicrobial products drive IL-23/IL-17- mediated tumour growth. Nature 2012;491:254-8.
14. Hope ME, Hold GL, Kain R, El-Omar EM. Sporadic colorectal cancer-role of the commensal microbiota. FEMS Microbiol Lett 2005;244:1-7.
15. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26:S6-14.
16. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
17. Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2006;290:G1157-63.
18. Rinaldi S, Rohrmann S, Jenab M, BiessyC, Sieri S, Palli D, et al. Glycosylated hemoglobin and risk of colorectal cancer inmenand women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008;17:3108-15.
19. Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, Rinaldi S, et al. Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation intoCancer and Nutrition.AmJ Epidemiol 2010; 172:407-18.
20. Aleksandrova K, Boeing H, Jenab M, BasBueno-de-Mesquita H, Jansen E, van Duijnhoven FJ, et al. Metabolic syndrome and risks of colon and rectal cancer: The European prospective investigation into cancer and nutrition study. Cancer Prev Res 2011;4:1873-83.
21. MurphyN, Norat T, Ferrari P, JenabM, Bueno-de-Mesquita B, Skeie G, et al. Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC). PLoS One 2012;7:e39361.
22. van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, Jenab M, Boshuizen HC, Ros MM, et al. Fruit, vegetables, and colorectal cancer risk: The European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009;89:1441-52.
23. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, et al. Meat, fish, and colorectal cancer risk: The European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005;97:906-16.
24. Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC, Vrieling A, Agudo A, et al. Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition Study. Clin Gastroenterol Hepatol 2011;9:137-44.
25. Steins Bisschop CN, van Gils CH, Emaus MJ, Bueno-de-Mesquita HB, Monninkhof EM, BoeingH, et al. Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study1, 3. Am J Clin Nutr 2014;99:139-47.
26. Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European Prospective Investigation intoCancer And Nutrition (EPIC). Int J Cancer 2007;121:2065-72.
27. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
28. Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 Macro. 2010.
29. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013; 13:800-12.
30. Fasano A. Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011;91:151-75.
31. Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009;27:443-9.
32. Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012;32:637-47.
33. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 2011;48:257-73.
34. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
35. Killeen SD, Wang JH, Andrews EJ, Redmond HP. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br J Cancer 2009;100:1589-602.
36. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-103.
37. Steiner TS. How flagellin and toll-like receptor 5 contribute to enteric infection. Infect Immun 2007;75:545-52.
38. Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, Keku TO. Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer 2013;13:91.
39. Lee KK, Yum KS. Association of endotoxins and colon polyp: a case-control study. J Korean Med Sci 2012;27:1062-5.
40. Wernli KJ, Ray RM, Gao DL, Thomas DB, Checkoway H. Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989-1998. Am J Ind Med 2003;44:595-9.
41. Hodgson JT, Jones RD.Mortality of workers in the British cotton industry in 1968-1984. Scand J Work Environ Health 1990;16:113-20.
42. Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, et al. Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst 2007;99:357-64.
43. Blair A, Sandler DP, Tarone R, Lubin J, Thomas K, Hoppin JA, et al. Mortality among participants in the agricultural health study. Ann Epidemiol 2005;15:279-85.
44. Szeszenia-Dabrowska N, Wilczynska U, Strzelecka A, Sobala W. Mortality in the cotton industry workers: results of a cohort study. Int J Occup Med Environ Health 1999;12:143-58.
45. Schmidt C. Immune system's Toll-like receptors have good opportunity for cancer treatment. J Natl Cancer Inst 2006;98:574-5.
46. Giron-Gonzalez JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I, et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000; 143:31-6.
47. Klein SL. The effects of hormones onsex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000;24:627-38.
48. Pellegrini P, Contasta I, Del Beato T, Ciccone F, Berghella AM. Genderspecific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer. Clin Dev Immunol 2011;2011: 819724.
49. Zeeuwen PL, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol 2012;13: R101.